Article Details

BioMarin Pharmaceutical (NASDAQ:BMRN) Earns Outperform Rating from Wedbush | MarketBeat

Retrieved on: 2021-10-29 12:07:14

Tags for this article:

Click the tags to see associated articles and topics

BioMarin Pharmaceutical (NASDAQ:BMRN) Earns Outperform Rating from Wedbush | MarketBeat. View article details on hiswai: https://www.marketbeat.com/instant-alerts/nasdaq-bmrn-a-buy-or-sell-right-now-2021-10-2-3/

Excerpt

Westside Investment Management Inc. now owns 4,720 shares of the biotechnology company's stock worth $6,530,000 after purchasing an additional 200 ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up